Gennex Laboratories Adjusts Evaluation Amid Strong Growth and Management Concerns

May 13 2025 08:32 AM IST
share
Share Via
Gennex Laboratories has recently experienced a change in its evaluation score, reflecting a shift in its technical outlook. The company has shown significant growth in operating profit and net sales over the past year, despite facing challenges in stock performance and profitability metrics.
Gennex Laboratories, a microcap player in the Pharmaceuticals & Drugs industry, has recently undergone an adjustment in its evaluation score. This revision reflects a shift in the technical landscape surrounding the stock, indicating a transition from a bearish outlook to a mildly bearish stance.

Key financial metrics reveal that Gennex Laboratories has demonstrated notable growth in its operating profit, with an annual increase of 48.58%. The company reported a significant rise in net sales, achieving an 87.05% growth, contributing to its positive performance over the last seven consecutive quarters. Despite these encouraging figures, the stock has faced challenges, including a return of -10.75% over the past year, contrasting with the broader market's performance.

The company's debt-to-equity ratio remains low at 0.07 times, suggesting a manageable level of debt. However, the return on equity (ROE) stands at 9.09%, indicating room for improvement in profitability relative to shareholders' funds. Additionally, the increase in pledged promoter shares to 23.87% raises questions about management efficiency.

Overall, the adjustment in Gennex Laboratories' evaluation reflects a complex interplay of growth metrics and technical indicators, highlighting both strengths and areas needing attention.

Discover the Latest Mojo Score and Financial Trend Performance - SignUp in less than 2 Minutes and get FREE Premium Access.
{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Why is Gennex Lab. falling/rising?
Nov 22 2025 01:12 AM IST
share
Share Via
Why is Gennex Lab. falling/rising?
Nov 17 2025 11:08 PM IST
share
Share Via
How has been the historical performance of Gennex Lab.?
Nov 15 2025 12:08 AM IST
share
Share Via
How has been the historical performance of Gennex Lab.?
Nov 13 2025 12:26 AM IST
share
Share Via
Why is Gennex Lab. falling/rising?
Nov 12 2025 11:00 PM IST
share
Share Via